{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:00:32Z","timestamp":1790028032469,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T00:00:00Z","timestamp":1474243200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00393-016-0202-3","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T09:34:21Z","timestamp":1474277661000},"page":"151-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Elevated serum levels of interleukin-1\u03b2 and interleukin-33 in patients with systemic sclerosis in Chinese population","Erh\u00f6hte Interleukin-1\u03b2- und Interleukin-33-Serumwerte bei Patienten mit systemischer Sklerose in einer chinesischen Population"],"prefix":"10.1007","volume":"77","author":[{"given":"Y.-J.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-L.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-P.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-Q.","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,19]]},"reference":[{"issue":"3","key":"202_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J\u00a0Clin Invest 117(3):557\u2013567","journal-title":"J Clin Invest"},{"issue":"5","key":"202_CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11926-013-0326-2","volume":"15","author":"K Naraghi","year":"2013","unstructured":"Naraghi K, van Laar JM (2013) Update on stem cell transplantation for systemic sclerosis: recent trial results. Curr Rheumatol Rep 15(5):326","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"202_CR3","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","volume":"130","author":"N Aden","year":"2010","unstructured":"Aden N, Nuttall A, Shiwen X, de Winter P, Leask\u00a0A, Black CM et al (2010) Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. J Invest Dermatol 130(9):2191\u20132200","journal-title":"J Invest Dermatol"},{"issue":"2","key":"202_CR4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jcp.2004.019224","volume":"58","author":"MR Hussein","year":"2005","unstructured":"Hussein MR, Hassan HI, Hofny ER, Elkholy M, Fatehy NA, Abd Elmoniem AE et\u00a0al (2005) Alterations of mononuclear inflammatory cells, CD4\/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis. J\u00a0Clin Pathol 58(2):178\u2013184","journal-title":"J Clin Pathol"},{"issue":"6","key":"202_CR5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda C, Dinarello CA, Mantovani A (2013) The interleukin-1 family: back to the future. Immunity 39(6):1003\u20131018","journal-title":"Immunity"},{"issue":"9","key":"202_CR6","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI4304","volume":"103","author":"Y Kawaguchi","year":"1999","unstructured":"Kawaguchi Y, Hara M, Wright TM (1999) Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A. J Clin Invest 103(9):1253\u20131260","journal-title":"J Clin Invest"},{"issue":"10","key":"202_CR7","first-page":"1946","volume":"31","author":"Y Kawaguchi","year":"2004","unstructured":"Kawaguchi Y, McCarthy SA, Watkins SC, Wright TM (2004) Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts. J\u00a0Rheumatol 31(10):1946\u20131954","journal-title":"J Rheumatol"},{"issue":"17","key":"202_CR8","doi-asserted-by":"crossref","first-page":"10008","DOI":"10.1073\/pnas.1737765100","volume":"100","author":"B Hu","year":"2003","unstructured":"Hu B, Wang S, Zhang Y, Feghali CA, Dingman JR, Wright TM (2003) A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression. Proc Natl Acad Sci USA 100(17):10008\u201310013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"202_CR9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/bbrc.1993.1024","volume":"190","author":"Y Kawaguchi","year":"1993","unstructured":"Kawaguchi Y, Harigai M, Suzuki K, Hara M, Kobayashi K, Ishizuka T et\u00a0al (1993) Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta. Biochem Biophys Res Commun 190(1):154\u2013161","journal-title":"Biochem Biophys Res Commun"},{"key":"202_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exger.2013.10.006","volume":"49","author":"MA Lim","year":"2014","unstructured":"Lim MA, Lee J, Park JS, Jhun JY, Moon YM, Cho ML et al (2014) Increased Th17 differentiation in aged mice is significantly associated with high IL-1beta level and low IL-2 expression. Exp Gerontol 49:55\u201362","journal-title":"Exp Gerontol"},{"issue":"6","key":"202_CR11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10875-014-0037-0","volume":"34","author":"S Vettori","year":"2014","unstructured":"Vettori S, Cuomo G, Iudici M, D\u2019Abrosca V, Giacco V, Barra G et al (2014) Early systemic sclerosis: serum profiling of factors involved in endothelial, T\u2011cell, and fibroblast interplay is marked by elevated interleukin-33 levels. J Clin Immunol 34(6):663\u2013668","journal-title":"J Clin Immunol"},{"issue":"10","key":"202_CR12","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/eji.200737547","volume":"37","author":"M Komai-Koma","year":"2007","unstructured":"Komai-Koma M, Xu D, Li Y, McKenzie AN, McInnes IB, Liew FY (2007) IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 37(10):2779\u20132786","journal-title":"Eur J Immunol"},{"issue":"6","key":"202_CR13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10067-011-1686-5","volume":"30","author":"K Yanaba","year":"2011","unstructured":"Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S (2011) Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin Rheumatol 30(6):825\u2013830","journal-title":"Clin Rheumatol"},{"issue":"10","key":"202_CR14","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/ard.2010.148247","volume":"70","author":"M Manetti","year":"2011","unstructured":"Manetti M, Guiducci S, Ceccarelli C, Romano E, Bellando-Randone S, Conforti ML et al (2011) Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement. Ann Rheum Dis 70(10):1876\u20131878","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"202_CR15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/annrheumdis-2012-201553","volume":"72","author":"S Terras","year":"2013","unstructured":"Terras S, Opitz E, Moritz RK, Hoxtermann S, Gambichler T, Kreuter A (2013) Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis. Ann Rheum Dis 72(1):144\u2013145","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"202_CR16","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s00296-012-2623-x","volume":"33","author":"WD Xu","year":"2013","unstructured":"Xu WD, Pan HF, Ye DQ (2013) Association of interleukin-18 and systemic lupus erythematosus. Rheumatol Int 33(12):3055\u20133057","journal-title":"Rheumatol Int"},{"issue":"10","key":"202_CR17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/jir.2011.0050","volume":"31","author":"MV Volin","year":"2011","unstructured":"Volin MV, Koch AE (2011) Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis. J Interferon Cytokine Res 31(10):745\u2013751","journal-title":"J Interferon Cytokine Res"},{"issue":"11","key":"202_CR18","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.30568","volume":"63","author":"CM Artlett","year":"2011","unstructured":"Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD (2011) The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum 63(11):3563\u20133574","journal-title":"Arthritis Rheum"},{"key":"202_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1874312901206010080","volume":"6","author":"CM Artlett","year":"2012","unstructured":"Artlett CM (2012) The role of the NLRP3 Inflammasome in fibrosis. Open Rheumatol J 6:80\u201386","journal-title":"Open Rheumatol J"},{"issue":"3","key":"202_CR20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/jid.2009.302","volume":"130","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Song SB, Choi JM, Kim KM, Cho BK, Cho DH et al (2010) IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway. J Invest Dermatol 130(3):706\u2013715","journal-title":"J Invest Dermatol"},{"issue":"5","key":"202_CR21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581\u2013590","journal-title":"Arthritis Rheum"},{"issue":"4","key":"202_CR22","doi-asserted-by":"crossref","first-page":"e96406","DOI":"10.1371\/journal.pone.0096406","volume":"9","author":"SN Slagter","year":"2014","unstructured":"Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, Boezen HM, Dullaart RP, Kobold AC et al (2014) Combined effects of smoking and alcohol on metabolic syndrome: the LifeLines cohort study. PLOS ONE 9(4):e96406","journal-title":"PLOS ONE"},{"key":"202_CR23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jch.12749","volume":"18","author":"XLJ Zhang","year":"2010","unstructured":"Zhang XLJ, Wang SH (2010) The effect of long-term alcohol intake on circadian rhythm of ambulatory blood pressure in males with hypertension. Chin J Hypertens 18:5","journal-title":"Chin J Hypertens"},{"issue":"6 Suppl 86","key":"202_CR24","first-page":"115","volume":"32","author":"J Huang","year":"2014","unstructured":"Huang J, Li M, Tian Z, Hsieh E, Wang Q, Liu Y et\u00a0al (2014) Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China. Clin Exp Rheumatol 32(6 Suppl 86):115\u2013121","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"202_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","volume":"35","author":"BW Needleman","year":"1992","unstructured":"Needleman BW, Wigley FM, Stair RW (1992) Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 35(1):67\u201372","journal-title":"Arthritis Rheum"},{"issue":"2","key":"202_CR26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1346-8138.12011","volume":"40","author":"T Maekawa","year":"2013","unstructured":"Maekawa T, Jinnin M, Ohtsuki M, Ihn H (2013) Serum levels of interleukin-1alpha in patients with systemic sclerosis. J Dermatol 40(2):98\u2013101","journal-title":"J Dermatol"},{"issue":"6","key":"202_CR27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/art.1780330619","volume":"33","author":"H Umehara","year":"1990","unstructured":"Umehara H, Kumagai S, Murakami M, Suginoshita T, Tanaka K, Hashida S et al (1990) Enhanced production of interleukin-1 and tumor necrosis factor alpha by cultured peripheral blood monocytes from patients with scleroderma. Arthritis Rheum 33(6):893\u2013897","journal-title":"Arthritis Rheum"},{"issue":"3","key":"202_CR28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-3083.2011.02567.x","volume":"74","author":"GN Andersen","year":"2011","unstructured":"Andersen GN, Nilsson K, Nagaeva O, Rantapaa-Dahlqvist S, Sandstrom T, Mincheva-Nilsson L (2011) Cytokine mRNA profile of alveolar T lymphocytes and macrophages in patients with systemic sclerosis suggests a local Tr1 response. Scand J Immunol 74(3):272\u2013281","journal-title":"Scand J Immunol"},{"issue":"12","key":"202_CR29","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1134\/S0006297914120049","volume":"79","author":"IV Astrakhantseva","year":"2014","unstructured":"Astrakhantseva IV, Efimov GA, Drutskaya MS, Kruglov AA, Nedospasov SA (2014) Modern anti-cytokine therapy of autoimmune diseases. Biochemistry Mosc 79(12):1308\u20131321","journal-title":"Biochemistry Mosc."},{"issue":"4","key":"202_CR30","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/eji.201343629","volume":"44","author":"KH Sturner","year":"2014","unstructured":"Sturner KH, Verse N, Yousef S, Martin R, Sospedra M (2014) Boswellic acids reduce Th17 differentiation via blockade of IL-1beta-mediated IRAK1 signaling. Eur J Immunol 44(4):1200\u20131212","journal-title":"Eur J Immunol"},{"issue":"2","key":"202_CR31","first-page":"19","volume":"10","author":"YM Mosaad","year":"2003","unstructured":"Mosaad YM, Metwally SS, Auf FA, AbdEL-Samee ER, el-Deek B, Limon NI et al (2003) Proinflammatory cytokines (IL-12 and IL-18) in immune rheumatic diseases: relation with disease activity and autoantibodies production. Egypt J Immunol 10(2):19\u201326","journal-title":"Egypt J Immunol"},{"issue":"12","key":"202_CR32","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/jid.2011.224","volume":"131","author":"HF Pan","year":"2011","unstructured":"Pan HF, Wang J, Leng RX, Li XP, Ye DQ (2011) Interleukin-18: friend or foe for systemic sclerosis? J Invest Dermatol 131(12):2495\u20132497","journal-title":"J Invest Dermatol"},{"issue":"24","key":"202_CR33","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1007\/s00018-013-1425-y","volume":"70","author":"SK Sedimbi","year":"2013","unstructured":"Sedimbi SK, Hagglof T, Karlsson MC (2013) IL-18 in inflammatory and autoimmune disease. Cell Mol Life Sci 70(24):4795\u20134808","journal-title":"Cell Mol Life Sci"},{"key":"202_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13252","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Asano Y, Taniguchi T, Minatsuki S, Inaba T, Maki H et al (2016) Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis. J Dermatol. doi:\n                        10.1111\/1346-8138.13252","journal-title":"J Dermatol"},{"issue":"5","key":"202_CR35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2\u2011associated cytokines. Immunity 23(5):479\u2013490","journal-title":"Immunity"},{"issue":"4","key":"202_CR36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00296-015-3417-8","volume":"36","author":"SS Koca","year":"2016","unstructured":"Koca SS, Pehlivan Y, Kara M, Alibaz-Oner F, Oztuzcu S, Yilmaz N et al (2016) The IL-33 gene is related to increased susceptibility to systemic sclerosis. Rheumatol Int 36(4):579\u2013584","journal-title":"Rheumatol Int"},{"issue":"6","key":"202_CR37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.smim.2013.10.005","volume":"25","author":"P Rider","year":"2013","unstructured":"Rider P, Carmi Y, Voronov E, Apte RN (2013) Interleukin-1alpha. Semin Immunol 25(6):430\u2013438","journal-title":"Semin Immunol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-016-0202-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0202-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0202-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T13:56:10Z","timestamp":1520517370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-016-0202-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,19]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1007\/s00393-016-0202-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,19]]}}}